FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048290796> ?p ?o ?g. }

• W3048290796 endingPage "272" @default.
• W3048290796 startingPage "272" @default.
• W3048290796 abstract "Abstract Background: Allogeneic hematopoietic stem cell transplantation (HCT) offers the best chance of cure for children suffering from high-risk (HR) acute myeloid leukemia (AML). Over the last decade, a consensus between study groups has increasingly been developed on when and how to perform HCTs in these patients. However, the fate of children experiencing AML relapse after a first allogeneic HCT remains dismal. Methods: With the aim of analyzing the outcome of children that had documented AML relapse after a first allogeneic HCT, we performed a retrospective analysis collecting data from cooperative groups participating in the I-BFM consortium. A questionnaire was developed aiming to collect comparable data on children that did or did not proceed to a second allogeneic HCT. The questionnaire was sent to the national study coordinators and completed by the national groups from Australia, Austria, Belgium, Czech Republic, Denmark, Finland, Germany, Israel, Italy, the Netherlands, New Zealand, Norway, Poland, Sweden, and Switzerland. Overall survival (OS) and event-free survival (EFS) were estimated from the date of relapse after the first allograft or 2nd HCT to the date of an event or last follow-up. Probabilities of OS and EFS were calculated according to the Kaplan and Meier method. Results: 336 patients experiencing relapse between January 2005 and December 2016 were identified. 199 were male and 137 female. The median age was 8.6 years (range 0.4; 26.0). 178 (53%) were younger than 10 years and 138 (47%) 10 years or older. 156 (47.4%) had originally been transplanted in CR1, 148 in CR2 (45.0%), and 25 for refractory disease (7.6%). OS and EFS for the total group was 14% (standard error, SE=0.02) and 2% (SE=0.01) at 4 years respectively. Survival curves were superimposable for patients that had been primarily transplanted in CR 1 (OS 15%) and CR2 (OS 15%). Children originally transplanted in refractory disease had a significantly inferior OS of 4% (p=0.009) once relapsed after 1st HCT. OS was comparable for children presenting with either HR or SR molecular and cytogenetic features before HCT (p=0.85). A time interval between 1st HCT and relapse 6 months after the 1st allograft, p Of note, only 123 (36.6%) children proceeded to a 2nd HCT. Importantly, the 4-year OS probability was 32% for children receiving a second transplant. This compared favorably with a 4-year OS of only 3% for those children who did not receive a 2nd HCT (p Graft source (bone marrow vs. peripheral blood stem cells/ cord blood, 49% versus 23%, p= 0.036, Fig. B) and donor type (matched sibling/ family donor vs. matched unrelated donor, 61% versus 14%, p=0.04, Fig. C) influenced patient's outcome after the 2nd allograft. Children experiencing any type of graft-versus-host disease (GVHD) had a better, although not statistically significant, probability of OS as compared to those who did not develop GVHD (47 % vs. 25%). Download : Download high-res image (117KB) Download : Download full-size image Figure . Disclosures Sauer: Neovii: Research Funding." @default.
• W3048290796 created "2020-08-13" @default.
• W3048290796 creator A5001935620 @default.
• W3048290796 creator A5002744343 @default.
• W3048290796 creator A5003666901 @default.
• W3048290796 creator A5015116246 @default.
• W3048290796 creator A5018866586 @default.
• W3048290796 creator A5021167347 @default.
• W3048290796 creator A5022712318 @default.
• W3048290796 creator A5030768031 @default.
• W3048290796 creator A5035808651 @default.
• W3048290796 creator A5054904756 @default.
• W3048290796 creator A5055400659 @default.
• W3048290796 creator A5057818328 @default.
• W3048290796 creator A5060561166 @default.
• W3048290796 creator A5064396176 @default.
• W3048290796 creator A5066050875 @default.
• W3048290796 creator A5066576257 @default.
• W3048290796 creator A5069107002 @default.
• W3048290796 creator A5075257247 @default.
• W3048290796 creator A5076502958 @default.
• W3048290796 creator A5077335202 @default.
• W3048290796 creator A5078858949 @default.
• W3048290796 creator A5085946966 @default.
• W3048290796 creator A5090105248 @default.
• W3048290796 creator A5090678844 @default.
• W3048290796 date "2017-12-07" @default.
• W3048290796 modified "2023-09-27" @default.
• W3048290796 title "Outcome of Children Relapsing after First Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia: A Retrospective I-BFM Analysis of 336 Children between 2005 and 2016" @default.
• W3048290796 doi "https://doi.org/10.1182/blood.v130.suppl_1.272.272" @default.
• W3048290796 hasPublicationYear "2017" @default.
• W3048290796 type Work @default.
• W3048290796 sameAs 3048290796 @default.
• W3048290796 citedByCount "0" @default.
• W3048290796 crossrefType "journal-article" @default.
• W3048290796 hasAuthorship W3048290796A5001935620 @default.
• W3048290796 hasAuthorship W3048290796A5002744343 @default.
• W3048290796 hasAuthorship W3048290796A5003666901 @default.
• W3048290796 hasAuthorship W3048290796A5015116246 @default.
• W3048290796 hasAuthorship W3048290796A5018866586 @default.
• W3048290796 hasAuthorship W3048290796A5021167347 @default.
• W3048290796 hasAuthorship W3048290796A5022712318 @default.
• W3048290796 hasAuthorship W3048290796A5030768031 @default.
• W3048290796 hasAuthorship W3048290796A5035808651 @default.
• W3048290796 hasAuthorship W3048290796A5054904756 @default.
• W3048290796 hasAuthorship W3048290796A5055400659 @default.
• W3048290796 hasAuthorship W3048290796A5057818328 @default.
• W3048290796 hasAuthorship W3048290796A5060561166 @default.
• W3048290796 hasAuthorship W3048290796A5064396176 @default.
• W3048290796 hasAuthorship W3048290796A5066050875 @default.
• W3048290796 hasAuthorship W3048290796A5066576257 @default.
• W3048290796 hasAuthorship W3048290796A5069107002 @default.
• W3048290796 hasAuthorship W3048290796A5075257247 @default.
• W3048290796 hasAuthorship W3048290796A5076502958 @default.
• W3048290796 hasAuthorship W3048290796A5077335202 @default.
• W3048290796 hasAuthorship W3048290796A5078858949 @default.
• W3048290796 hasAuthorship W3048290796A5085946966 @default.
• W3048290796 hasAuthorship W3048290796A5090105248 @default.
• W3048290796 hasAuthorship W3048290796A5090678844 @default.
• W3048290796 hasConcept C109159458 @default.
• W3048290796 hasConcept C126322002 @default.
• W3048290796 hasConcept C167135981 @default.
• W3048290796 hasConcept C187212893 @default.
• W3048290796 hasConcept C2777408962 @default.
• W3048290796 hasConcept C2778461978 @default.
• W3048290796 hasConcept C2778729363 @default.
• W3048290796 hasConcept C28328180 @default.
• W3048290796 hasConcept C2911091166 @default.
• W3048290796 hasConcept C2993713153 @default.
• W3048290796 hasConcept C54355233 @default.
• W3048290796 hasConcept C71924100 @default.
• W3048290796 hasConcept C86803240 @default.
• W3048290796 hasConcept C88879693 @default.
• W3048290796 hasConceptScore W3048290796C109159458 @default.
• W3048290796 hasConceptScore W3048290796C126322002 @default.
• W3048290796 hasConceptScore W3048290796C167135981 @default.
• W3048290796 hasConceptScore W3048290796C187212893 @default.
• W3048290796 hasConceptScore W3048290796C2777408962 @default.
• W3048290796 hasConceptScore W3048290796C2778461978 @default.
• W3048290796 hasConceptScore W3048290796C2778729363 @default.
• W3048290796 hasConceptScore W3048290796C28328180 @default.
• W3048290796 hasConceptScore W3048290796C2911091166 @default.
• W3048290796 hasConceptScore W3048290796C2993713153 @default.
• W3048290796 hasConceptScore W3048290796C54355233 @default.
• W3048290796 hasConceptScore W3048290796C71924100 @default.
• W3048290796 hasConceptScore W3048290796C86803240 @default.
• W3048290796 hasConceptScore W3048290796C88879693 @default.
• W3048290796 hasLocation W30482907961 @default.
• W3048290796 hasOpenAccess W3048290796 @default.
• W3048290796 hasPrimaryLocation W30482907961 @default.
• W3048290796 hasRelatedWork W2119288719 @default.
• W3048290796 hasRelatedWork W2175655704 @default.
• W3048290796 hasRelatedWork W2480738100 @default.
• W3048290796 hasRelatedWork W2519269008 @default.
• W3048290796 hasRelatedWork W2559081822 @default.
• W3048290796 hasRelatedWork W2572075405 @default.
• W3048290796 hasRelatedWork W2599582889 @default.
• W3048290796 hasRelatedWork W2760940434 @default.

• next